In conclusion, we explored the prognostic value based on the expression level of TRHDE-AS1 by lasso regression to predict clinical outcomes in glioma patients, which suggested that this lncRNA had great potential to guide clinical prognosis prediction and decision making for treatment in the future. The gene discussed is TRHDE; the disease is central nervous system cancer.